ARTEGRAFT AG745

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a distributor,health profession report with the FDA on 2016-06-25 for ARTEGRAFT AG745 manufactured by Artegraft, Inc..

Event Text Entries

[48191309] Artegraft, inc. Performed a review of the batch history record. Upon release, the batch met all requirements including pressure test results and graft wall thickness. Product evaluation was not able to be performed as the graft remains implanted and the patient is reported to be in stable condition. Photographs of the surgery prior to the suture of the graft "slit" were provided; however, no conclusions were able to be made based on the images. To date, no additional complaints were reported from the same product batch and no complaints for the same issue of implanted graft "blow out' were received in the past 2 years. It is unknown if procedural issues and/or patient interaction contributed to the reported event. The complaint issue will continue to be monitored within artegraft, inc. Quality systems, quality assurance trending. Graft remains implanted.
Patient Sequence No: 1, Text Type: N, H10


[48191310] An artegraft, inc. Approved distributor reported on behalf of the vascular surgeon that an artegraft (collagen vascular graft) which was implanted a "couple of weeks ago" "blew out"; a hole was noticed in the side of the graft. Upon follow-up communications, it was stated that the patient previously had blood flow issues and as a result, lost toes due to failed limb salvage. The artegraft was implanted in the patient's right femoral to popliteal during a limb salvage procedure on (b)(6) 2016. The reporter was unsure if the artegraft ifu required step for pre-implant pressure testing was performed by the surgical team. It was also stated that this was the hospitals first attempt at using an artegraft in a lower extremity. A few weeks after the surgery, the patient alleged noticeable irritation under the skin in the graft location. The surgeon initially attempted to place a vascular stent however, it failed in performance. Further exam identified a graft rupture. When the patient's leg was operated on (b)(6) 2016, coagulated blood was seen and about 3 cm from the anastomosis there was a ~1 cm "slit" in the graft. The surgeon was able to successfully suture the "slit" in the graft. The graft remains implanted and the patient is reported to be in stable condition.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2247686-2016-00008
MDR Report Key5750026
Report SourceDISTRIBUTOR,HEALTH PROFESSION
Date Received2016-06-25
Date of Report2016-05-27
Date of Event2016-05-27
Date Mfgr Received2016-05-27
Device Manufacturer Date2016-06-08
Date Added to Maude2016-06-25
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactCYNTHIA SALTER
Manufacturer Street206 NORTH CENTER DRIVE
Manufacturer CityNORTH BRUNSWICK NJ 089024247
Manufacturer CountryUS
Manufacturer Postal089024247
Manufacturer Phone7324228333
Manufacturer G1ARTEGRAFT, INC
Manufacturer Street206 NORTH CENTER DRIVE
Manufacturer CityNORTH BRUNSWICK NJ 089024247
Manufacturer CountryUS
Manufacturer Postal Code089024247
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameARTEGRAFT
Generic NameCOLLAGEN VASCULAR GRAFT
Product CodeLXA
Date Received2016-06-25
Model NumberAG745
Catalog NumberAG745
Lot Number15D102-014
Device Expiration Date2018-04-30
OperatorPHYSICIAN
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerARTEGRAFT, INC.
Manufacturer Address206 NORTH CENTER DRIVE NORTH BRUNSWICK NJ 089024247 US 089024247


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2016-06-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.